StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.67+0.12 (+4.71%)

Close on Nov 17, 2026Market cap $92.82MP/E –Yield –

Anixa Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Anixa Biosciences's price to book ratio was 6.6× on Nov 11, 2026, against 9.1× a year earlier. Over the last 5 years it ranged from 2.4× to 9.1×, with a median of 4.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.6×−0.1
2025Dec 31, 20256.8×+3.1
2024Dec 31, 20243.7×−1.2
2023Dec 29, 20235.0×+0.4
2022Dec 30, 20224.5×+2.0
2021Dec 31, 20212.5×−6.0
2020Dec 31, 20208.5×−4.2
2019Dec 31, 201912.7×−1.0
2018Dec 31, 201813.7×+8.8
2017Dec 29, 20174.9×−42.9
2016Dec 30, 201647.9×+42.7
2015Dec 31, 20155.2×−0.8
2014Dec 31, 20146.0×−23.3
2012May 31, 201229.3×+11.0
2011Dec 30, 201118.3×+11.3
2010Dec 31, 20107.0×–

More Anixa Biosciences figures

See a number that looks wrong?